Targacept (TRGT) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Targacept (TRGT)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: mopgcw	9/28/2006 11:07:04 AM
	Read Replies (1) of 40

interesting, at the IPO, original investors were in @ ~ $9.78/share assuming all options exercised so the IPO was well less than current basis. I despise the 3-class board nonsense; but they have it; Major holders at the offering: New Enterprise Associates 15.3 % EuclidSR Partners, L.P. 9.9 % Nomura Phase4 Ventures Limited 11.2 % Oxford Bioscience Partners 4.7 % R.J. Reynolds 5.8 % Burrill & Company LLC 4.1 % Advent Private Equity Fund II 3.7 % Insiders: Donald deBethizy, 1.9% M. James Barrett, 15.3% Charles A. Blixt 5.8% Ann F. Hanham 4.1% Elaine V. Jones 9.9% Looks like New Enterprise dumped about half their position; euclid is out altogether; Wellington took in a decent stake and BVF & millenium joined for a small amount. Deferred license fee revenut of 10.5mm which seems odd on the sheets;

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next